Ciprofloxacin lactate
Ciprofloxacin lactate Basic information
- Product Name:
- Ciprofloxacin lactate
- Synonyms:
-
- 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid lactate
- CIPROFLOXACIN LACTATE
- mono(2-hydroxypropanoate)
- Ciprofloxacin lactate CP2000
- Ciprofloxacine lactate
- CIPROFLOXACIN-QACID
- CIPROFLOXACIN LACTAT
- 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,2-hydroxypropanoic acid
- CAS:
- 97867-33-9
- MF:
- C20H24FN3O6
- MW:
- 421.43
- EINECS:
- 1806241-263-5
- Product Categories:
-
- Antibiotic
- API
- Pharmacutical raw materials
- Pharmaceutical intermediates
- Active Pharmaceutical Ingredients
- Mol File:
- 97867-33-9.mol
Ciprofloxacin lactate Chemical Properties
- Melting point:
- 255-257°C
- storage temp.
- Inert atmosphere,Room Temperature
- solubility
- DMSO (Slightly), Methanol (Slightly, Heated)
- form
- Solid
- color
- White to Off-White
- CAS DataBase Reference
- 97867-33-9(CAS DataBase Reference)
Safety Information
- Safety Statements
- 24/25
- HS Code
- 29339900
Ciprofloxacin lactate Usage And Synthesis
Uses
Ciprofloxacin Lactate is an antibiotic that has been used to medicate polymer wound dressing. Ciprofloxacin Lactate has been shown to produce high and sustained serum bactericidal titers against highly susceptible bacteria.
in vivo
Ciprofloxacin (Bay-09867) lactate (30 mg/kg; i.p.; for 24 hours; BALB/c mice) has protection against Y. pestis in murine model of pneumonic plague[3].
Ciprofloxacin (Bay-09867) lactate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) accelerates aortic root enlargement and increases the incidence of aortic dissection and rupture by decreases LOX level and increases MMP levels and activity in the aortic wall[4].
Ciprofloxacin (Bay-09867) lactate (100 mg/kg; i.g.; daily, for 4 weeks; C57BL/6J mice) induces DNA damage and release of DNA to the cytosol, mitochondrial dysfunction, and activation of cytosolic DNA sensor signaling. Ciprofloxacin lactate increases apoptosis and necroptosis in the aortic wall[4].
| Animal Model: | BALB/c mice[3] |
| Dosage: | 30 mg/kg |
| Administration: | Intraperitoneal injection; for 24 hours |
| Result: | Reduced the lung bacterial load in murine model of pneumonic plague. |
| Animal Model: | C57BL/6J mice[4] |
| Dosage: | 100 mg/kg |
| Administration: | Oral gavage; daily, for 4 weeks |
| Result: | Had aortic destruction that was accompanied by decreased LOX expression and increased MMP expression and activity. |
| Animal Model: | C57BL/6J mice[4] |
| Dosage: | 100 mg/kg |
| Administration: | Oral gavage; daily, for 4 weeks |
| Result: | Caused mitochondrial DNA and nuclear DNA damage, leading to mitochondrial dysfunction and ROS production. Increased apoptosis and necroptosis in the aortic wall. |
IC 50
Quinolone
Ciprofloxacin lactate Supplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-58099652-8005 13585536065
- bin.wu@shlschem.com
- Tel
- 15527768836
- 1791901229@qq.com
- Tel
- 400-1166-196 18981987031
- cdhxsj@163.com
- Tel
- 0086-21-58956006
Ciprofloxacin lactate (97867-33-9)Related Product Information
- Ciprofloxacin hydrochloride hydrate
- Sodium lactate
- N-Aminoethylpiperazine
- 2-Ethylhexyl ferulate
- Quinclorac
- Ciprofloxacin hydrochloride
- Ciprofloxacin
- Isoquinoline
- Dihydromyrcenol
- Ethoxyquin
- Ethacridine lactate monohydrate
- Trimethoprim lactate salt
- Norfloxacin
- Fluorine
- Hydrogen
- LACTATE
- Ciprofloxacin lactate
- fluoro jade